Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Masahiro Hirakawa, MD PhD, Tiago R Matos, MD MSc, Edouard Forcade, MD, Kathy S. Wang, PhD, Eduardo L Espada, MD, Jennifer Whangbo, MD PhD, Carol G Reynolds, PhD, Marie J Chammas, Kazuyuki Murase, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 3425.

https://doi.org/10.1182/blood.V126.23.3425.3425

Published: 2015

Journal Articles

Long-Term Homeostatic Effects of Daily Low-Dose IL-2 on CD4+ FoxP3+ Regulatory T Cells in Patients with Active Chronic Graft-Versus-Host Disease

Jennifer Whangbo, MD PhD, John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Katharine Dusenbury, Ana Cristina Alho, MD, Carol G Reynolds, PhD, Marie J Chammas, Kyle T Jones, Sarah Nikiforow, MD PhD, Corey S Cutler, MD MPH, Vincent T. Ho, MD, Philippe Armand, MD PhD, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD

Blood (2015) 126 (23): 3133.

https://doi.org/10.1182/blood.V126.23.3133.3133

Published: 2015

Journal Articles

Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Ana Cristina Alho, MD, Kim T Haesook, PhD, Carol G Reynolds, PhD, Marie J Chammas, BSc, Sean McDonough, MS, Suzan Lazo-Kallanian, John Daley, PhD, Sarah Nikiforow, MD PhD, Corey S Cutler, MD MPH, John Koreth, MBBS, DPhil, Vincent T Ho, MD, Philippe Armand, MD PhD, Robert J. Soiffer, MD, Joseph H Antin, MD, Jerome Ritz, MD

Blood (2014) 124 (21): 2496.

https://doi.org/10.1182/blood.V124.21.2496.2496

Published: 2014

Journal Articles

Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Phase 2 and Long Term Efficacy, Safety and Immune Correlates

John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Kyle T. Jones, BSc, Carol G Reynolds, PhD, Marie J Chammas, BSc, Katherine Dusenbury, BSc, Jennifer Whangbo, MD PhD, Sarah Nikiforow, MD PhD, Edwin P. Alyea, MD, Philippe Armand, MD PhD, Corey S Cutler, MD MPH, Vincent T Ho, MD, Yi-Bin Chen, MD, David Avigan, MD, Joseph H Antin, MD, Jerome Ritz, MD, Robert J Soiffer, MD

Blood (2014) 124 (21): 41.

https://doi.org/10.1182/blood.V124.21.41.41

Published: 2014

Journal Articles

Differential Plasma Cytokine Levels in Patients with and without Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Caron A. Jacobson, MD, Joshua Geary, Haesook T Kim, PhD, Sean McDonough, MS, Carol G Reynolds, PhD, Maria I. Herrera, MD, PhD, John Koreth, MBBS, DPhil, Corey Cutler, MD, MPH, FRCPC, Vincent T Ho, MD, Edwin P Alyea, III, MD, Philippe Armand, MD, PhD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD

Blood (2012) 120 (21): 4476.

https://doi.org/10.1182/blood.V120.21.4476.4476

Published: 2012

Journal Articles

Patterns of B Cell Activating Factor (BAFF) Levels, B Cell Recovery, and BAFF/B Cell Ratios Correlate with the Development of Chronic Graft-Versus-Host Disease (cGVHD) Following Hematopoietic Stem Cell Transplantation (HSCT)

Caron A. Jacobson, MD, Haesook T Kim, PhD, Stefanie Sarantopoulos, MD, PhD, Lixian Sun, MS, Sean McDonough, MS, Carol G Reynolds, PhD, Maria I. Herrera, MD, PhD, John Koreth, MBBS, DPhil, Corey S. Cutler, MD, MPH, FRCPC, Vincent T Ho, MD, Edwin P Alyea, III, MD, Philippe Armand, MD, PhD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD

Blood (2011) 118 (21): 3036.

https://doi.org/10.1182/blood.V118.21.3036.3036

Published: 2011

NARROW

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Long-Term Homeostatic Effects of Daily Low-Dose IL-2 on CD4+ FoxP3+ Regulatory T Cells in Patients with Active Chronic Graft-Versus-Host Disease

Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Phase 2 and Long Term Efficacy, Safety and Immune Correlates

Differential Plasma Cytokine Levels in Patients with and without Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Patterns of B Cell Activating Factor (BAFF) Levels, B Cell Recovery, and BAFF/B Cell Ratios Correlate with the Development of Chronic Graft-Versus-Host Disease (cGVHD) Following Hematopoietic Stem Cell Transplantation (HSCT)

Email alerts

ASH Publications

American Society of Hematology

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Long-Term Homeostatic Effects of Daily Low-Dose IL-2 on CD4+ FoxP3+ Regulatory T Cells in Patients with Active Chronic Graft-Versus-Host Disease

Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Phase 2 and Long Term Efficacy, Safety and Immune Correlates

Differential Plasma Cytokine Levels in Patients with and without Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Patterns of B Cell Activating Factor (BAFF) Levels, B Cell Recovery, and BAFF/B Cell Ratios Correlate with the Development of Chronic Graft-Versus-Host Disease (cGVHD) Following Hematopoietic Stem Cell Transplantation (HSCT)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only